Recent advances in recombinant adeno-associated virus vector production
- 1 January 2002
- journal article
- review article
- Published by Elsevier in Kidney International
- Vol. 61 (1) , S9-S15
- https://doi.org/10.1046/j.1523-1755.2002.0610s1009.x
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genomeThe Journal of Gene Medicine, 2000
- High-Titer Recombinant Adeno-Associated Virus Production from Replicating Amplicons and Herpes Vectors Deleted for Glycoprotein HHuman Gene Therapy, 1999
- High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and CapGene Therapy, 1999
- Recombinant adeno-associated virus purification using novel methods improves infectious titer and yieldGene Therapy, 1999
- Cellular contaminants of adeno-associated virus vector stocks can enhance transductionGene Therapy, 1999
- Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirusGene Therapy, 1999
- High-Titer Adeno-Associated Viral Vectors from a Rep/Cap Cell Line and Hybrid Shuttle VirusHuman Gene Therapy, 1998
- Factors Influencing Recombinant Adeno-Associated Virus ProductionHuman Gene Therapy, 1998
- Replication of rep-cap Genes Is Essential for the High-Efficiency Production of Recombinant AAVHuman Gene Therapy, 1997
- Cell Lines for the Production of Recombinant Adeno-Associated VirusHuman Gene Therapy, 1995